Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5025,800.62.27%H 25,808.8 · L 25,345.2as of 20 Nov, 3:31 PM IST|Sensex83,919.712.3%H 84,037.96 · L 82,403.27as of 20 Nov, 3:32 PM IST|Bank Nifty64,635.24.19%H 64,680.8 · L 62,598.55as of 20 Nov, 3:31 PM IST|USD / INR₹92.660.66%H ₹92.67 · L ₹92.66as of 7:55 PM IST|Gold Intl (10g)₹1,04,726.794.62%H ₹1,08,382.13 · L ₹1,04,354.4as of 21 Nov, 3:29 AM IST|Silver Intl (1kg)₹1,22,351.067.41%H ₹1,28,636.93 · L ₹1,20,995.58as of 21 Nov, 3:29 AM IST|Crude WTI₹7,728.771.18%H ₹7,789.93 · L ₹7,485.07as of 21 Nov, 3:29 AM IST|Bitcoin₹55,53,6773.49%H ₹56,50,723.9 · L ₹54,56,630.1as of 3:07 PM IST|Ethereum₹1,56,4143.16%H ₹1,58,885.87 · L ₹1,53,942.13as of 3:07 PM IST|Nifty 5025,800.62.27%H 25,808.8 · L 25,345.2as of 20 Nov, 3:31 PM IST|Sensex83,919.712.3%H 84,037.96 · L 82,403.27as of 20 Nov, 3:32 PM IST|Bank Nifty64,635.24.19%H 64,680.8 · L 62,598.55as of 20 Nov, 3:31 PM IST|USD / INR₹92.660.66%H ₹92.67 · L ₹92.66as of 7:55 PM IST|Gold Intl (10g)₹1,04,726.794.62%H ₹1,08,382.13 · L ₹1,04,354.4as of 21 Nov, 3:29 AM IST|Silver Intl (1kg)₹1,22,351.067.41%H ₹1,28,636.93 · L ₹1,20,995.58as of 21 Nov, 3:29 AM IST|Crude WTI₹7,728.771.18%H ₹7,789.93 · L ₹7,485.07as of 21 Nov, 3:29 AM IST|Bitcoin₹55,53,6773.49%H ₹56,50,723.9 · L ₹54,56,630.1as of 3:07 PM IST|Ethereum₹1,56,4143.16%H ₹1,58,885.87 · L ₹1,53,942.13as of 3:07 PM IST|
0%
IPOsBreaking

Fabtech Technologies IPO: Check Price Band, GMP Trends and Key Dates

Arth Vani DeskPublished: 1 min read
Fabtech Technologies IPO: Check Price Band, GMP Trends and Key Dates

Source: GNews IPO

Arth Insight · What this means for your wallet

Immediate action
Monitor official IPO dates and price band announcements for Fabtech Technologies.
  • This IPO offers a potential opportunity to invest in a company serving the growing global pharma sector.
  • Investing in IPOs carries risk; only invest what you can afford to lose.
  • A successful IPO could lead to listing gains, but there's no guarantee.
Recommended for you
Track live & upcoming IPOs
View IPO Center
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Fabtech Technologies is preparing for its public market debut with an upcoming IPO. The company, which specializes in turnkey solutions for pharmaceutical and biotech industries, has set its sights on the primary market to fund its expansion plans.

Key Highlights
  • ▸Fabtech Technologies is launching an IPO to fund its global pharmaceutical engineering projects.
  • ▸The company specializes in cleanroom technology and biotech manufacturing setups.
  • ▸Investors should track the official price band and lot size announcements for final valuation details.
  • ▸GMP trends suggest early interest, but official listing gains will depend on market conditions at the time of debut.
Key Takeaways
  • ✓Fabtech Technologies is launching an IPO to fund its global pharmaceutical engineering projects.
  • ✓The company specializes in cleanroom technology and biotech manufacturing setups.
  • ✓Investors should track the official price band and lot size announcements for final valuation details.
  • ✓GMP trends suggest early interest, but official listing gains will depend on market conditions at the time of debut.

Fabtech Technologies, a prominent player in the engineering and construction space for the pharmaceutical and healthcare sectors, is gearing up for its Initial Public Offering (IPO). The company provides end-to-end turnkey solutions, including the design and installation of cleanrooms and specialized manufacturing equipment for global biotech firms.

IPO Structure and Price Band

While the final price band and specific issue size are being finalized through the book-building process, market participants are closely watching the Grey Market Premium (GMP) for early signals of investor sentiment. The IPO is expected to consist of a fresh issue of equity shares, aimed at strengthening the company's balance sheet and meeting working capital requirements for large-scale international projects.

Business Outlook and Growth Drivers

Fabtech has established a significant footprint in over 50 countries, positioning itself as a key exporter of Indian engineering expertise. The company’s growth is closely tied to the global expansion of the pharmaceutical industry and the increasing demand for high-standard manufacturing facilities in emerging markets.

  • Global Presence: Strong execution track record in Asia, Africa, and the Middle East.
  • Sector Focus: High-growth niche in pharmaceutical engineering and cleanroom technology.
  • Financial Health: Focus on utilizing IPO proceeds for debt reduction and operational scaling.

What Investors Should Watch

Retail investors should monitor the official announcement of the lot size and the specific dates for subscription. As with all engineering and construction-heavy businesses, the company's ability to manage project timelines and raw material costs will be critical to its long-term profitability. The Grey Market Premium (GMP) currently reflects a cautious but positive outlook, though it is important to remember that GMP is an unofficial indicator and not a guarantee of listing performance.

This report is for informational purposes only and does not constitute financial advice. IPO investments are subject to market risks.

Recommended for you
Products related to this story — compare & act
Smart picks
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
13.8%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
13.0%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
12.7%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
12.7%
3Y CAGR

IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.

Frequently Asked Questions

What does Fabtech Technologies do?

Fabtech Technologies provides turnkey engineering solutions, specifically designing and building cleanrooms and manufacturing facilities for the pharmaceutical and biotech industries.

How will the IPO proceeds be used?

The company intends to use the funds from the fresh issue for working capital requirements, potential debt repayment, and general corporate purposes.

Where can I check the Fabtech IPO allotment status?

Once the subscription period closes, investors can check their allotment status on the website of the IPO's official registrar or the BSE/NSE websites.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

Monomark Engineering IPO: Price Band, Dates, and Lot Size Revealed
IPOBreaking
IPOs

Monomark Engineering IPO: Price Band, Dates, and Lot Size Revealed

Monomark Engineering's Initial Public Offering (IPO) is set to open on [Date] with a price band of ₹[Lower Price] to ₹[Upper Price] per share. The IPO aims to raise ₹[Issue Size] through a fresh issue of shares.

just now·1 min readListen
Mahanadi CoalFields IPO GMP Plunges 92% to ₹0.7 Amid Weak Bidding Interest
IPOBreaking
IPOs

Mahanadi CoalFields IPO GMP Plunges 92% to ₹0.7 Amid Weak Bidding Interest

The Grey Market Premium (GMP) for Mahanadi CoalFields' Initial Public Offering (IPO) has seen a sharp decline of 92%, falling from ₹9.25 to just ₹0.7. This significant drop comes as the IPO struggles to attract sufficient investor bids, signaling subdued market sentiment for the offering.

15h ago·2 min readListen
Integris Medtech IPO: GMP Trend Under Watch, Specifics Awaited
IPO
IPOs

Integris Medtech IPO: GMP Trend Under Watch, Specifics Awaited

Market observers are keenly tracking the Grey Market Premium (GMP) for the upcoming Integris Medtech IPO today. While the unofficial trend is being monitored, specific GMP figures and other crucial IPO details were not available in the provided source material.

15h ago·1 min readListen
Mahanadi Coalfields IPO to Offer 10% Stake Through Offer For Sale
IPOBreaking
IPOs

Mahanadi Coalfields IPO to Offer 10% Stake Through Offer For Sale

Mahanadi Coalfields, a key subsidiary of Coal India Limited, is reportedly planning an Initial Public Offering (IPO) that will include the sale of a 10% stake through an Offer For Sale (OFS). This move indicates a potential disinvestment exercise, although specific details regarding the IPO's timing, price band, and total issue size are yet to be officially announced.

15h ago·2 min readListen